Search For "serum institute of india"
SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold i
Updated : 4 years, 3 months ago IST
New Delhi [India], April 12 (ANI): Chief Executive Officer (CEO) of Serum Institute of India (SII) Adar Poonawalla on Tuesday informed that the company has exported nearly 40 million COVID vaccine doses to European countries and Australia, and said that the Covovax is the first vaccine made
Read More
Slashed COVID-19 vaccine Covishield's prices to ensure more accessibility,
Updated : 4 years, 3 months ago IST
New Delhi [India], April 12 (ANI): The decision to slash the prices of the precautionary dose of the COVID-19 vaccine Covishield, which is now available for all adults, was taken to make it more affordable, accessible and within reach of the masses, Chief Executive Officer (CEO) of Serum
Read More
COVID vaccine: Covishield's price reduced from Rs 600 to Rs 225 per dose a
Updated : 4 years, 3 months ago IST
Pune (Maharashtra) [India], April 9 (ANI): Pune-based Serum Institute of India (SII) on Saturday announced that it has revised the price of its COVID vaccine Covishield for private hospitals from Rs 600 to Rs 225 per dose.
Read More
Adar Poonawalla lauds Centre's work during COVID pandemic
Updated : 4 years, 3 months ago IST
Pune (Maharashtra) [India], April 4 (ANI): Amid the overall cases and positivity rate declining in the country and states like Maharashtra, West Bengal and Himachal Pradesh revoking the COVID restrictions, Adar Poonawalla, Chief Executive Officer (CEO) of Serum Institute of India (SII), p
Read More
NTAGI to review data of SII's COVID-19 vaccine Covovax on Friday: Sources
Updated : 4 years, 3 months ago IST
New Delhi [India], March 30 (ANI): The COVID-19 working group of the National Technical Advisory on Immunisation (NTAGI) will be reviewing the data of Serum Institute of India's vaccine -- Covovax for use for children and adults, on April 1, sources informed on Wednesday.
Read More
DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax
Updated : 4 years, 4 months ago IST
New Delhi [India], March 9 (ANI): The Drugs Controller General of India (DCGI) has granted Emergency Use Authorisation (EUA) to Serum Institute of India's (SII) COVID-19 vaccine Covovax for adults and for children above the age of 12 years.
Read More
SEC recommends granting emergency use authorisation to Serum Institute of
Updated : 4 years, 4 months ago IST
New Delhi [India], March 4 (ANI): The Subject Expert Committee (SEC) has recommended granting emergency use authorisation (EUA) to Serum India of India's COVID-19 vaccine Covovax for the age group 12-17, said the official sources.
Read More
SII provided COVID-19 vaccine at 'cost of cup of tea', saved nearly two-th
Updated : 4 years, 5 months ago IST
Pune (Maharashtra) [India], February 14 (ANI): Padma Bhushan-awardee and industrialist Cyrus Poonawala on Monday said Serum Institute of India (SI) provided COVID-19 vaccine at "the cost of a cup of tea" and saved nearly two-thirds infant population in the world.
Read More
Thank govt for acknowledging my mentor, my hero: Adar Poonawalla on his fa
Updated : 4 years, 5 months ago IST
New Delhi [India], January 25 (ANI): Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year.
Read More
SII Chairman and MD Cyrus Poonawalla to be conferred with Padma Bhushan
Updated : 4 years, 5 months ago IST
New Delhi [India], January 25 (ANI): Serum Institute of India (SII) Chairman and Managing Director Cyrus Poonawalla will be conferred with Padma Bhushan, announced the Centre on Tuesday, on the eve of the 73rd Republic Day.
Read More
SEC recommends regular market approval to Covaxin, Covishield for adults
Updated : 4 years, 5 months ago IST
New Delhi [India], January 19 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee (SEC) has recommended the regular market approval to Serum Institute of India and Bharat Biotech for their COVID-19 vaccines Covaxin and Covishield with conditions for the adult po
Read More
SEC asks for more data to grant full market approval to Covaxin and Covish
Updated : 4 years, 6 months ago IST
New Delhi [India], January 14 (ANI): The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, sources
Read More